Cipla is engaged in the Business of Pharmaceuticals.
Financial Results:
Cipla Ltd reported Revenues for Q4FY24 of ₹6,163.00 Crores up from ₹5,739.00 Crore year on year, a rise of 7.39%.
Total Expenses for Q4FY24 of ₹5,153.00 Crores up from ₹4,946.00 Crores year on year, a rise of 4.19%.
Consolidated Net Profit of ₹932.00 Crores up 78.54% from ₹522.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹11.63, up 78.65% from ₹6.51 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.